{"id":"NCT01462942","sponsor":"AstraZeneca","briefTitle":"Long-term Efficacy and Safety of Aclidinium Bromide/Formoterol Fumarate Fixed-Dose Combination","officialTitle":"Efficacy and Safety of Aclidinium Bromide/Formoterol Fumarate Fixed-dose Combinations Compared With Individual Components and Placebo When Administered to Patients With Stable Chronic Obstructive Pulmonary Disease.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-10","primaryCompletion":"2013-01","completion":"2013-01","firstPosted":"2011-11-01","resultsPosted":"2017-02-15","lastUpdate":"2017-02-15"},"enrollment":2443,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Obstructive Pulmonary Disease (COPD)"],"interventions":[{"type":"DRUG","name":"Aclidinium Bromide/Formoterol Fumarate","otherNames":[]},{"type":"DRUG","name":"Aclidinium Bromide/Formoterol Fumarate","otherNames":[]},{"type":"DRUG","name":"Aclidinium Bromide","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Formoterol Fumarate","otherNames":[]}],"arms":[{"label":"Aclidinium/Formoterol 400/6 μg","type":"EXPERIMENTAL"},{"label":"Aclidinium/Formoterol 400/12 μg","type":"EXPERIMENTAL"},{"label":"Aclidinium monotherapy 400 μg","type":"EXPERIMENTAL"},{"label":"Formoterol monotherapy 12 μg","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The objective is to provide data supporting the use of LAS40464 as an efficacious and safe maintenance bronchodilator treatment of patients with Chronic Obstructive Pulmonary Disease (COPD).","primaryOutcome":{"measure":"Change From Baseline in 1-hour Morning Post-dose Forced Expiratory Volume in One Second (FEV1)","timeFrame":"Baseline and Week 24","effectByArm":[{"arm":"Placebo","deltaMin":-0.03,"sd":0.018},{"arm":"Aclidinium/Formoterol 400/12 μg","deltaMin":0.269,"sd":0.013},{"arm":"Aclidinium/Formoterol 400/6 μg","deltaMin":0.213,"sd":0.013},{"arm":"Aclidinium 400 μg","deltaMin":0.144,"sd":0.013},{"arm":"Formoterol 12 μg","deltaMin":0.129,"sd":0.013}],"pValues":[{"comp":"OG001 vs OG003","p":"<0.0001"},{"comp":"OG002 vs OG003","p":"0.0001"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":11},"locations":{"siteCount":197,"countries":["Austria","Belgium","Bulgaria","Croatia","Czechia","Denmark","Finland","France","Germany","Hungary","Italy","Netherlands","Poland","Romania","Russia","Slovakia","South Africa","South Korea","Spain","Sweden","Ukraine","United Kingdom"]},"refs":{"pmids":["31827323","28558833","26233481","25404569"],"seeAlso":["http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=3970&filename=M-40464-30-CSRsynopsis.pdf"]},"adverseEventsSummary":{"seriousAny":{"events":12,"n":194},"commonTop":["Chronic obstructive pulmonary disease","Headache","Nasopharyngitis","Back pain"]}}